Tumour Necrosis Factor Release in Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: Fine needle aspiration assessing tumour TNFa levels
Sponsor: Lawson Health Research Institute